B
Baelurlalee
Global leader in quantitative ultrasound solutions - The world’s first ultrasound technology to quantitatively characterize cell properties from ultrasound radio-frequency signals
About Baelurlalee
Barreleye is a South Korean medical technology company, established in 2021, that operates in the diagnostic assistance market. The company was founded by Professor Hyunmin Bae, who also serves as the CEO, leveraging his background as a faculty member in the School of Electrical Engineering and Dean of the KAIST Startup Institute. The firm's technological foundation stems from research that began in a KAIST lab, focusing on applying artificial intelligence to quantitative ultrasound.
Barreleye's business centers on developing and providing AI-powered software solutions that analyze ultrasound signals to quantify cellular and biomechanical tissue characteristics. This technology assists medical professionals in making more informed diagnostic decisions. The company's business model is likely based on licensing its software to hospitals, clinics, and global medical device manufacturers. Barreleye has secured approximately $10 million in a Series A funding round from a strategic global healthcare corporation, adding to earlier seed investments from Mirae Holdings and KAIC To Ventures. This funding is aimed at accelerating global clinical studies, securing regulatory approvals, and moving towards full-scale commercialization.
The company has developed a suite of products for different clinical applications. The Intelligence (Int) series analyzes the biomechanical properties of tissue. 'Int-BUS' is a solution for breast cancer diagnosis that provides a probability of malignancy, which was designated as an innovative medical device in South Korea. 'Int-HUS' measures hepatic fat proportion to aid in the early detection of fatty liver disease. The Vision (Vis) series focuses on image analysis. 'Vis-BUS' provides real-time detection of abnormal lesions in breast ultrasounds, while 'Vis-CUS' is an AI-based tool for assessing cardiac function from echocardiography images. These solutions are designed to work with existing ultrasound equipment, enhancing their diagnostic capabilities without requiring new hardware.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Seoul, South Korea
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 84.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Health Diagnostics, AI for medical imaging
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2025 | $12M | $47M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Baelurlalee is 3.9K monthly website visits, up 39.3% over the last three months. Baelurlalee's team grew 62.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
BeamWorksAI-powered medical imaging for real-time cancer diagnosis |
Daegu, South Korea | Operational | 12 | $13M | $50M |
| Warsaw, Poland | Operational | ||||
Evom AIAI-powered diagnostics for proactive cardiovascular care. |
Seoul, South Korea | Operational | |||
| Hefei, China | Operational | ||||
EnAcuityAI-powered, software-only hyperspectral surgical imaging |
London, United Kingdom | Operational | |||
AiopticsAI-powered handheld device for point-of-care retinal screening |
Huangpu, China | Operational | |||
Macula Vision SystemsAI-powered computational microscopy for clinical sample analysis |
Tucson, United States | Operational | |||
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning |
Oxford, United Kingdom | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
KAIST ILP
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Baelurlalee on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Baelurlalee’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





